National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 1) (PB 7 of 2019) (Cth)

PB 7 of 2019

National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 1)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated          29 January 2019

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

_________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 1).

(2)This Instrument may also be cited as PB 7 of 2019.

1. Commencement

This Instrument commences on 1 February 2019.

1. Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

1. Schedule 1, after entry for Amlodipine with atorvastatin in the form Tablet 10 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium)

insert:

Amlodipine with valsartan	Tablet 5 mg (as besilate)- 80 mg	Oral	Exforge 5/80	28	7.42	10.21
Tablet 5 mg (as besilate)- 160 mg	Oral	Exforge 5/160	28	9.31	12.10
Tablet 5 mg (as besilate)- 320 mg	Oral	Exforge 5/320	28	11.72	14.51
Tablet 10 mg (as besilate)- 160 mg	Oral	Exforge 10/160	28	9.91	12.70
Tablet 10 mg (as besilate)- 320 mg	Oral	Exforge 10/320	28	12.32	15.11
Amlodipine with valsartan and hydrochlorothiazide	Tablet 5 mg (as besilate)- 160 mg- 12.5 mg	Oral	Exforge HCT 5/160/12.5	28	10.72	13.51
Tablet 5 mg (as besilate)- 160 mg- 25 mg	Oral	Exforge HCT 5/160/25	28	12.13	14.92
Tablet 10 mg (as besilate)- 160 mg- 12.5 mg	Oral	Exforge HCT 10/160/12.5	28	11.32	14.11
Tablet 10 mg (as besilate)- 160 mg- 25 mg	Oral	Exforge HCT 10/160/25	28	12.73	15.52
Tablet 10 mg (as besilate)- 320 mg- 25 mg	Oral	Exforge HCT 10/320/25	28	15.14	17.93

1. Schedule 1, entry for Dutasteride Capsule 500 micrograms

omit from the column headed “Claimed price”:   18.29     substitue:              22.01

1. Schedule 1, omit entry for Valsartan